LSKL, Inhibitor of Thrombospondin (TSP-1),CAS :283609-79-0
LSKL, Inhibitor of Thrombospondin (TSP-1)
Product description
This peptide, derived from the latency-associated peptide, inhibits thrombospondin (TSP-1) activation of TGF-beta; thus preventing the progression of hepatic damage and fibrosis.
| Appearance | N/A |
|---|---|
| Molecular weight | N/A |
| Purity | >90% |
| Solubility | N/A |
| Cas | 283609-79-0 |
| Sequence | H-Leu-Ser-Lys-Leu-NH2 (trifluoroacetate salt)/Leu-Ser-Lys-Leu-NH2/LSKL-NH2 |
| Molecular Formula | C21H42N6O5 |
| Storage | -20℃,protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 year |
Document
Related Product

Items-$0.00

Email:
Tel.:
msds of LSKL, Inhibitor of Thrombospondin (TSP-1)
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


